首页 工具
登录
购物车
NM-3

NM-3

产品编号 T33701   CAS 181427-78-1
别名: NM-3, isocoumarin, NM 3, Isocoumarin NM-3, NM3

NM-3 是一种可口服的抗血管生成的抑制剂,具有抗肿瘤活性。NM-3在体外和体内可当作辐射调节剂使用。NM-3抑制血管内皮生长因子(VEGF),从而抑制内皮细胞的增殖。NM-3与活性氧的机制诱导细胞凋亡有关。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
NM-3 Chemical Structure
NM-3, CAS 181427-78-1
规格 价格/CNY 货期 数量
1 mg ¥ 1,330 现货
5 mg ¥ 3,330 现货
10 mg ¥ 4,850 现货
25 mg ¥ 7,630 现货
50 mg ¥ 9,870 现货
100 mg ¥ 13,800 现货
500 mg ¥ 27,800 现货
1 mL * 10 mM (in DMSO) ¥ 2,930 现货
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
重组蛋白限时优惠
Doxorubicin hydrochloride限时半价
产品目录号及名称: NM-3 (T33701)
点击图片重新获取验证码
选择批次  
TargetMol batch loading
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 NM-3 is an orally available anti-angiogenic inhibitor with anti-tumour activity.NM-3 is used as a radiation modulator in vitro and in vivo.NM-3 inhibits vascular endothelial growth factor (VEGF), thereby inhibiting the proliferation of endothelial cells. This inhibits the proliferation of endothelial cells. NM-3 is associated with a mechanism of apoptosis induction by reactive oxygen species.
体外活性 NM-3 (100 ng/ml) is cytotoxic to human umbilical vein endothelial cells (HUVECs) but not to Lewis lung carcinoma (LLC) cells nor Seg-1, esophageal adenocarcinoma cells, in clonogenic survival assays (1,000 ng/ml ; 4h).[1]
体内活性 C57BL/6 female mice bearing LLC tumors were given injections for 4 consecutive days with NM-3 (25 mg/kg/day) and treated with IR (20 Gy) for 2 consecutive days. Combined treatment with NM-3 and IR significantly reduced mean tumor volume compared with either treatment alone. An increase in local tumor control was also observed in LLC tumors in mice receiving NM-3/IR therapy. When athymic nude mice bearing Seg-1 tumor xenografts were treated with NM-3 (100 mg/kg/day for 4 days) and 20 Gy (four 5 Gy fractions), significant tumor regression was observed after combined treatment (NM-3 and IR) compared with IR alone. Importantly, no increase in systemic or local tissue toxicity was observed after combined treatment (NM-3 and IR) when compared with IR alone. The bioavailability and nontoxic profile of NM-3 suggests that the efficacy of this agent should be tested in clinical radiotherapy.[1]
别名 NM-3, isocoumarin, NM 3, Isocoumarin NM-3, NM3
分子量 264.23
分子式 C13H12O6
CAS No. 181427-78-1

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 27.5 mg/mL (104.08 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.7846 mL 18.9229 mL 37.8458 mL 94.6145 mL
5 mM 0.7569 mL 3.7846 mL 7.5692 mL 18.9229 mL
10 mM 0.3785 mL 1.8923 mL 3.7846 mL 9.4615 mL
20 mM 0.1892 mL 0.9461 mL 1.8923 mL 4.7307 mL
50 mM 0.0757 mL 0.3785 mL 0.7569 mL 1.8923 mL
100 mM 0.0378 mL 0.1892 mL 0.3785 mL 0.9461 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Salloum RM, et al. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res. 2000 ; 60(24):6958-6963. 2. Zhu JS, et al. Molecule action mechanisms of NM-3 on human gastric cancer SGC-7901 cells in vivo or in vitro. World J Gastroenterol. 2003 ; 9(10):2366-2369. 3. Agata N, et al. Suppression of type II collagen-induced arthritis by a new isocoumarin, NM-Res Commun Mol Pathol Pharmacol. 2000 ; 108(5-6):297-309. 4. Yin L, et al. The novel isocoumarin 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid (NM-3) induces lethality of human carcinoma cells by generation of reactive oxygen species. Mol Cancer Ther. 2001 ; 1(1):43-48.
Copanlisib Hypericin Casein Kinase inhibitor A51 Selonsertib Taurodeoxycholic acid sodium hydrate Poziotinib PluriSIn 1 Naphthazarin

相关化合物库

该产品包含在如下化合物库中:
抑制剂库 抗癌活性化合物库 免疫/炎症分子化合物库 线粒体靶向库 NF-κB 通路分子库 经典已知活性库 抗癌化合物库 已知活性化合物库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

NM-3 181427-78-1 Apoptosis Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species isocoumarin NM 3 Isocoumarin NM-3 NM3 Inhibitor inhibitor inhibit

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼